SARS-CoV2

SARS - CoV2
  • 文章类型: Journal Article
    通过利用锌(Zn)等天然元素对创新的非药物治疗途径进行研究的动机是发现了新的严重急性呼吸综合征相关冠状病毒2(SARS-COV2)变体以及某些疫苗接种治疗在COVID-19大流行期间无效。此外,对SARS-COV-2病毒进入细胞和感染机制的研究表明,它可能严重危害年轻男性和青少年的生殖系统细胞并损害睾丸功能,随着时间的推移,这可能会导致男性不育。在这种情况下,我们进行了叙述性审查,以概述有关锌在睾丸组织中的关键作用的数据,这种微量营养素的治疗用途,以提高男性的生育能力,以及在COVID-19的潜在缓解中,最终目标是阐明潜在使用锌补充剂来预防SARS-COV2感染对睾丸生理功能可能产生的有害影响的假设,随后,关于男性生育能力。
    Research into innovative non-pharmacological therapeutic routes via the utilization of natural elements like zinc (Zn) has been motivated by the discovery of new severe acute respiratory syndrome-related coronavirus 2 (SARS-COV2) variants and the ineffectiveness of certain vaccination treatments during COVID-19 pandemic. In addition, research on SARS-COV-2\'s viral cellular entry and infection mechanism has shown that it may seriously harm reproductive system cells and impair testicular function in young men and adolescents, which may lead to male infertility over time. In this context, we conducted a narrative review to give an overview of the data pertaining to Zn\'s critical role in testicular tissue, the therapeutic use of such micronutrients to enhance male fertility, as well as in the potential mitigation of COVID-19, with the ultimate goal of elucidating the hypothesis of the potential use of Zn supplements to prevent the possible harmful effects of SARS-COV2 infection on testis physiological function, and subsequently, on male fertility.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    哮喘是一种常见的慢性肺部疾病,和COVID-19作为呼吸道病毒性疾病的大流行导致肺部感染,并导致数百万人死亡。所以,应明确COVID-19对哮喘结局的影响以及感染或住院的风险.通过搜索2019年12月1日至2023年7月31日之间的电子数据库,对COVID-19患者的哮喘结果和风险进行了系统评价和荟萃分析。来自遍布各大洲的27个国家的总共48项研究被纳入审查。COVID-19患者的哮喘患病率为7.9%,分析表明,与无哮喘的受试者相比,有哮喘的受试者获得COVID-19的风险比降低了16.5%.住院风险差异无统计学意义,ICU入院风险,与无哮喘的COVID-19患者相比,无哮喘的COVID-19患者的死亡风险。非哮喘患者和哮喘患者死于COVID-19的风险相似。研究结果表明,与没有哮喘的受试者相比,患有哮喘的受试者感染COVID-19的风险可能更低,但他们有相似的住院和死亡风险。
    Asthma is a common chronic lung disease, and COVID-19 pandemic as a respiratory viral disease led to lung infection and resulted in millions of deaths. So, the impact of COVID-19 on asthma outcomes and the risk of being infected or hospitalized should be clarified. Systematic review and meta-analysis on the outcomes and risk of asthma for people with COVID-19 was done by searching electronic databases between 1 December 2019 and 31 July 2023. A total of 48 studies from 27 countries spread across all continents were included in the review. The prevalence of asthma among COVID-19 patients was 7.9%, and the analysis demonstrated a 16.5% reduction in the risk ratio for acquiring COVID-19 among subjects with asthma compared to those without asthma. There was no statistically significant difference in hospitalization risk, ICU admission risk, and death risk for COVID-19 patients with no asthma compared to those with asthma. The risk of death from COVID-19 was similar between nonasthmatics and asthmatics. The findings indicated that subjects with asthma may be at a lower risk of having infection with COVID-19 compared to those without asthma, but they have a similar risk of hospitalization and mortality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    新兴出版物表明,糖尿病使COVID-19患者容易出现更严重的并发症,部分归因于炎症。在当前的审查中,我们回顾了最近发表的文献,以提供胰岛素抵抗(IR)在糖尿病中的作用的证据,糖尿病与COVID-19严重程度和死亡率之间的关系,COVID-19感染对新发糖尿病的影响,COVID-19患者IR的机制,以及不同替代IR对COVID-19的预测价值。
    文献检索旨在找出评估IR替代与COVID-19患者发病率和死亡率之间关系的研究。
    我们表明,有大量证据支持以下事实:糖尿病是COVID-19患者发病率和死亡率增加的有效危险因素。与没有糖尿病的患者相比,患有糖尿病的COVID-19患者更容易出现明显的血糖异常,这与不利的预后有关。此外,SARS-COV2可以通过激活ISR使患者易患IR和糖尿病,影响RAAS信号通路,引起炎症,改变PPAR和SREBP-1的表达。此外,较高的IR与COVID-19患者的发病率和死亡率增加相关,不同的IR替代指标可作为COVID-19患者的预后生物标志物.
    IR的不同替代指标可用作COVID-19并发症和死亡的预测因子。
    UNASSIGNED: Emerging publications indicate that diabetes predisposes patients with COVID-19 to more severe complications, which is partly attributed to inflammatory condition. In the current review, we reviewed recent published literature to provide evidence on the role of insulin resistance (IR) in diabetes, the association between diabetes and COVID-19 severity and mortality, the impact of COVID-19 infection on incident new-onset diabetes, mechanisms responsible for IR in COVID-19 patients, and the predictive value of different surrogates of IR in COVID-19.
    UNASSIGNED: The literature search performs to find out studies that have assessed the association between IR surrogates and morbidity and mortality in patients with COVID-19.
    UNASSIGNED: We showed that there is a bulk of evidence in support of the fact that diabetes is a potent risk factor for enhanced morbidity and mortality in COVID-19 patients. COVID-19 patients with diabetes are more prone to remarkable dysglycemia compared to those without diabetes, which is associated with an unfavourable prognosis. Furthermore, SARS-COV2 can make patients predispose to IR and diabetes via activating ISR, affecting RAAS signaling pathway, provoking inflammation, and changing the expression of PPARɣ and SREBP-1. Additionally, higher IR is associated with increased morbidity and mortality in COVID-19 patients and different surrogates of IR can be utilized as a prognostic biomarker for COVID-19 patients.
    UNASSIGNED: Different surrogates of IR can be utilized as predictors of COVID-19 complications and death.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)是一种高度传染性和危险的病毒,在2020年初引起了全球COVID-19大流行。它主要影响呼吸系统,导致世界范围内的严重疾病和高死亡率。病毒通过与称为ACE2的受体结合进入体内,该受体存在于称为2型肺泡上皮细胞的肺部特定细胞中。许多研究调查了SARS-CoV-2感染的后果,揭示了对身体的各种影响。这篇综述概述了SARS-CoV-2,包括其结构和如何感染细胞。它还检查了关注的不同变体,比如阿尔法,Beta,Gamma,Delta,以及最近的Omicron变体,讨论它们的特征和它们造成的损害程度。治疗COVID-19的药物的使用是已经涵盖的另一个方面,并比较了抗病毒药物在治疗中的有效性和使用以及其在COVID-19治疗中的潜在益处。此外,这篇综述探讨了与SARS-CoV-2感染相关的后果和异常,包括它对体内各种器官和系统的影响。还讨论了可用的不同COVID-19疫苗及其在预防感染和降低疾病严重程度方面的有效性。当前的审查确保了最新的COVID研究与专家的知识,从可靠的来源和方法中收集大量数据,并根据审查更新调查结果。这篇综述还提供了清晰的上下文解释,以帮助解释和应用结果。本手稿的主要座右铭和局限性是解决针对快速发展的SARS-CoV-2病毒的药物发现的计算方法,已经讨论过了。此外,还讨论了当前的计算方法,这些计算方法具有成本效益,并且能够预测用于抗病毒治疗的治疗剂。
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a highly contagious and dangerous virus that caused the global COVID-19 pandemic in early 2020. It primarily affects the respiratory system, leading to severe illness and high rates of mortality worldwide. The virus enters the body by binding to a receptor called ACE2, which is present in specific cells of the lungs known as type 2 alveolar epithelial cells. Numerous studies have investigated the consequences of SARS-CoV-2 infection, revealing various impacts on the body. This review provides an overview of SARS-CoV-2, including its structure and how it infects cells. It also examines the different variants of concern, such as Alpha, Beta, Gamma, Delta, and the more recent Omicron variant, discussing their characteristics and the level of damage they cause. The usage of drugs to treat COVID-19 is another aspect that has been covered and compares the effectiveness and use of antiviral drugs in the treatment and its potential benefits in COVID-19 treatment. Furthermore, this review explores the consequences and abnormalities associated with SARS-CoV-2 infection, including its impact on various organs and systems in the body. And also discussing the different COVID-19 vaccines available and their effectiveness in preventing infection and reducing the severity of illness. The current review ensures the recent update of the COVID research with expert\'s knowledge, collection of numerous data from reliable sources and methodologies as well as update of findings based on reviews. This review also provided clear contextual explanations to aid the interpretation and application of the results. The main motto and limitation of this manuscript are to address the computational methods of drug discovery against the rapidly evolving SARS-CoV-2 virus, which has been discussed. Additionally, current computational approaches which are cost effective and can able to predict the therapeutic agents for the treatment against the virus have also been discussed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目标:鉴于人们越来越关注SARS-CoV2感染与自身免疫性疾病之间的可能联系,我们进行了回顾,以调查大流行爆发对甲状腺疾病的影响.
    方法:我们对文献中描述的所有儿科病例进行了叙述性回顾,主要关注COVID-19与自身免疫性和感染后甲状腺疾病(即桥本甲状腺炎(HT),严重疾病(GD)和亚急性甲状腺炎(SAT))。我们还认为有必要简要回顾非甲状腺疾病综合征(NTIS)和儿童多系统炎症综合征(MIS-C),因为它们与甲状腺炎重叠。
    结果:目前尚无确凿的证据表明SARS-CoV-2感染与小儿年龄的自身免疫性甲状腺炎(AT)发病率增加有关。然而,SAT可能是SARS-CoV-2感染的轻度并发症,与其他病毒感染一样。SAT通常自己解决,不需要治疗。NTIS可能与炎症并发症有关,例如MIS-C,和重症监护病房的入院。它也可能被认为是严重疾病的预后风险因素。COVID-19中甲状腺损伤的假设发病机制包括由于甲状腺中血管紧张素转换酶2(ACE2)的显着表达而引起的直接损伤,这是病毒的配体,以及免疫失调造成的间接损害,例如IL-6的过度产生,这被认为是甲状腺炎发病机制的一部分。
    结论:然而,由于现有的证据有限,需要进一步的前瞻性纵向研究来阐明COVID-19与儿童和青少年甲状腺疾病之间的关系,以及调查任何潜在的长期后果。
    OBJECTIVE: In light of the growing concern over the possible link between SARS-CoV2 infection and autoimmune diseases, we conducted a review to investigate the impact of the pandemic outbreak on thyroid diseases.
    METHODS: We carried out a narrative review of all pediatric cases described in the literature, mainly focusing on the possible association of COVID-19 with the incidence of autoimmune and post-infective thyroid diseases (namely Hashimoto\'s Thyroiditis (HT), Grave\'s Disease (GD) and Sub-Acute Thyroiditis (SAT)). We also felt it was necessary to provide a brief review of Non-thyroidal Illness Syndrome (NTIS) and Multisystem Inflammatory Syndrome in Children (MIS-C) because of their overlap with thyroiditis.
    RESULTS: There is currently no conclusive evidence linking SARS-CoV-2 infection with an increased incidence of autoimmune thyroiditis (AT) in pediatric age. However, SAT may be a mild complication of SARS-CoV-2 infection, as is the case with other viral infections. SAT typically resolves on its own and does not require treatment. NTIS may be associated with inflammatory complications, such as MIS-C, and admission to intensive care. It may also be considered a prognostic risk factor for severe disease. The hypothesized pathogenetic mechanisms of thyroid damage in COVID-19 include direct damage due to the significant expression of angiotensin-converting enzyme 2 (ACE2) in the thyroid gland, which is a ligand for the virus, and indirect damage due to immune dysregulation, such as the overproduction of IL-6, which is thought to be part of the pathogenesis of thyroiditis.
    CONCLUSIONS: However, due to the limited evidence available, further prospective longitudinal studies are required to clarify the relationship between COVID-19 and thyroid disease in children and adolescents, as well as to investigate any potential long-term consequences.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    背景:研究SARS-CoV-2对男性生殖功能的影响的研究很少且异质,结果往往是相互矛盾的。这项系统评价和荟萃分析是对患有活动性或记忆性SARS-CoV-2感染的男性进行的研究,以评估其对男性性激素谱和精液参数的影响。
    方法:本荟萃分析遵循系统评价和荟萃分析(PRISMA)方案的首选报告项目。PubMed,Scopus,科克伦,检索Embase数据库以确定相关研究。我们最初选择了3553篇文章。资格阶段之后,16篇文章符合我们的纳入标准,包括11项病例对照研究和5项队列研究(2项前瞻性研究和3项回顾性研究)。采用综合Meta分析软件进行定量分析。Cochran-Q和异质性(I2)指数用于评估统计异质性。还进行了敏感性分析和发表偏倚测试。
    结果:总体而言,包括1250名活跃或近期(80天前)感染COVID-19的患者和1232名匹配的健康对照。精子浓度,精子总数,与对照组相比,患者的总运动明显较低。患者的总睾酮和卵泡刺激素水平也较低,和更高水平的促黄体激素,17β-雌二醇,与健康对照组相比,催乳素。纳入的研究均未发现感染患者的精液中存在SARS-CoV-2mRNA。
    结论:本系统综述和荟萃分析提示SARS-CoV-2感染与原发性睾丸损伤之间存在关联,表现为类固醇生成改变和精子发生恶化。精液中不存在病毒表明感染向伴侣和后代的性传播可能性较低。然而,我们的发现主要是短期随访,虽然很少有研究考虑病毒感染的长期后果,因此,需要进一步的研究来评估对男性生殖健康的长期影响。
    BACKGROUND: Studies investigating the effects of SARS-CoV-2 on male reproductive function are few and heterogeneous, and results are often conflicting. This systematic review and meta-analysis was carried out on studies conducted in men with active or anamnestic SARS-CoV-2 infection to evaluate its consequences on the male sex hormone profile and semen parameters.
    METHODS: This meta-analysis follows the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) protocols. PubMed, Scopus, Cochrane, and Embase databases were searched to identify relevant studies. We originally selected 3553 articles. After the eligibility phase, 16 articles met our inclusion criteria encompassing 11 case-control studies and 5 cohort studies (2 prospective and 3 retrospective studies). We performed the quantitative analysis with Comprehensive Meta-Analysis Software. Cochran-Q and heterogeneity (I2) indexes were used to assess statistical heterogeneity. Sensitivity analysis and publication bias tests were also performed.
    RESULTS: Overall, 1250 patients with active or recent (up to 80 days before) COVID-19 infection and 1232 matched healthy controls were included. Sperm concentration, total sperm count, and total motility were significantly lower in patients compared with controls. Patients also showed lower levels of total testosterone and follicle-stimulating hormone, and higher levels of luteinizing hormone, 17β-estradiol, and prolactin compared with healthy controls. None of the included studies found the presence of SARS-CoV-2 mRNA in the semen of infected patients.
    CONCLUSIONS: The present systematic review and meta-analysis suggests the presence of an association between SARS-CoV-2 infection and primary testicular damage manifested with a picture of altered steroidogenesis and worsening spermatogenesis. The absence of the virus in the seminal fluid indicates a low possibility of sexual transmission of the infection to partners and offspring. However, our findings mostly show short-term follow-up, while few studies have considered the long-term consequences of the viral infection, thus further studies are needed to evaluate the long-term consequences on male reproductive health.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Systematic Review
    背景:退行性脊髓型颈椎病是一系列退行性脊柱病理继发的症状性颈脊髓压迫。患有DCM的人并不罕见地报告呼吸症状,例如呼吸急促,并且在几项DCM研究中已经描述了呼吸功能障碍。因此,本综述的目的是系统地综合有关DCM与呼吸功能之间关系的当前证据。
    方法:该综述在PROSPERO上注册,并遵守PRISMA指南。OvidMEDLINE和Embase从成立到2023年3月14日进行了搜索。报告与呼吸功能或疾病有关的任何测量或结果的DCM研究均合格。手工检索了纳入研究的参考列表和相关评论文章。Title,摘要和全文筛选,偏差风险和等级评估一式两份完成.提出了定量合成。
    结果:在1991年通过文献检索确定的研究中,13项符合纳入标准:3项队列研究,5个病例对照研究,1个案例系列和4个案例研究。强迫肺活量(FVC),据报道,DCM患者的最大呼气流量(PEFR)和最大自主通气(MVV)低于对照组;1s内用力呼气量(FEV1)的比较存在不一致。关于手术减压是否与呼吸参数的改善以及脊髓压迫水平与呼吸功能障碍之间的关系,存在矛盾的证据。
    结论:DCM可能与呼吸功能障碍有关。然而,目前证据的一致性和质量较低。进一步的工作应更严格地描述DCM患者的呼吸功能障碍,并研究假定的机制,例如对引起diaphragm肌神经支配的颈神经根的破坏以及对来自脑干呼吸中心的下行脊柱投射的损害。
    BACKGROUND: Degenerative cervical myelopathy is a condition of symptomatic cervical spinal cord compression secondary to a range of degenerative spinal pathology. Respiratory symptoms such as shortness of breath are not uncommonly reported by people with DCM and respiratory dysfunction has been described in several DCM studies. The objective of this review was therefore to systematically synthesise the current evidence on the relationship between DCM and respiratory function.
    METHODS: The review was registered on PROSPERO and adhered to PRISMA guidelines. Ovid MEDLINE and Embase were searched from inception to 14th March 2023. DCM studies reporting on any measure or outcome relating to respiratory function or disease were eligible. Reference lists of included studies and relevant reviews articles were hand searched. Title, abstract and full text screening, risk of bias and GRADE assessments were completed in duplicate. A quantitative synthesis is presented.
    RESULTS: Of 1991 studies identified by literature searching, 13 met inclusion criteria: 3 cohort studies, 5 case-control studies, 1 case series and 4 case studies. Forced vital capacity (FVC), peak expiratory flow rate (PEFR) and maximal voluntary ventilation (MVV) were reported to be lower in DCM patients than controls; there was inconsistency in comparisons of forced expiratory volume in 1 s (FEV1). There was conflicting evidence on whether surgical decompression was associated with improvements in respiratory parameters and on the relationship between level of spinal cord compression and respiratory dysfunction.
    CONCLUSIONS: DCM may be associated with respiratory dysfunction. However, consistency and quality of evidence is currently low. Further work should characterise respiratory dysfunction in DCM patients more rigorously and investigate putative mechanisms such as disruption to cervical nerve roots responsible for diaphragmatic innervation and damage to descending spinal projections from brainstem respiratory centres.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    最近由SARS-CoV-2引起的COVID-19大流行影响了数亿人,并导致数百万人死亡。针对SARS-CoV-2的有效药物很少,有一些研究试图制造基于天然成分的药物,比如橄榄叶。橄榄叶富含多酚化合物,这些药物被提议作为治疗和改善COVID-19患者临床症状的可行联合治疗补充剂。多酚对几个病毒家族有著名的抗炎和多靶点抗病毒作用,这可能是地中海饮食对COVID-19有益影响的原因之一。本文综述了橄榄树多酚作为自然疗法抑制SARS-CoV-2的作用,主要讨论了它们对病毒通过内吞进入宿主细胞的过程的影响。
    The recent COVID-19 pandemic caused by SARS-CoV-2 affected hundreds of millions of people and caused millions of deaths. There are few effective medications against SARS-CoV-2, and several studies attempted to make drugs based on natural components, such as olive leaves. Olive leaves are rich in polyphenolic compounds, which were proposed as a viable co-therapy supplement to treat and improve clinical symptoms in COVID-19 patients. Polyphenols have renown anti-inflammatory and multitarget antiviral effects on several virus families, which could be among the reasons of the beneficial effects of the Mediterranean diet against COVID-19. This scoping review is focused on the effect of olive tree polyphenols as a natural remedy to inhibit SARS-CoV-2, mainly discussing their influence on the process of viral entry into host cells by endocytosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    全球COVID-19爆发,始于2019年12月,导致严重的财务损失和非同寻常的健康危机。寻找有效且安全的候选药物来治疗SARS-CoV-2感染及其症状仍然是全球迫切需要。在回顾了以前的研究之后,橄榄叶,富含多酚化合物(植物中天然存在的一大类生物活性物质),被提议作为一种可行的联合治疗补充剂来治疗和改善COVID-19患者的临床症状。人们早就知道,橄榄树多酚-如橄榄苦苷,羟基酪醇,Verbascoside,以及三萜类化合物,如maslinic,熊,齐墩果酸对几个病毒家族有抗炎和多靶点抗病毒作用,它们可能是地中海饮食对COVID-19有益影响的原因之一。因此,橄榄树多酚在电脑和体外测试,以防止SARS-CoV-2感染,声称它们有有益的效果。然而,关于这一主题的研究仍然很少。这项范围审查的目的是提供更多信息,并就使用橄榄树多酚作为创建针对这种病毒性疾病的创新自然疗法的跳板的可行性提供意见。最终规划未来的相关研究。
    UNASSIGNED: The global COVID-19 outbreak, started in December 2019, resulted in severe financial losses and extraordinary health crises. Finding a potent and secure medication candidate to treat SARS-CoV-2 infection and its symptoms is still an urgent global need. After reviewing previous studies, olive leaves, being rich in polyphenolic compounds (a large class of bioactive substances naturally found in plants), were proposed as a viable co-therapy supplement to treat and improve clinical symptoms in COVID-19 patients. It has long been known that olive tree polyphenols-such as oleuropein, hydroxytyrosol, verbascoside, as well as triterpenoids like maslinic, ursolic, and oleanolic acids-have anti-inflammatory and multitarget antiviral effects on several virus families, and they could be one of the reasons of the beneficial effects of the Mediterranean diet against COVID-19. Thus, olive tree poly-phenols were tested in silico and in vitro for preventing SARS-CoV-2 infection, claiming that they have beneficial effects. Nevertheless, there is still a small number of research studies on this topic. The aim of this scoping review is to provide more information and offer an opinion on the feasibility of using olive tree polyphenols as a springboard for the creation of innovative natural remedies against this viral illness, ultimately planning future relevant studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    COVID-19大流行影响了全球大量孕妇,但是关于免疫反应的研究却得出了相互矛盾的结果。本研究旨在系统地回顾SARS-CoV-2感染孕妇及其婴儿的细胞因子谱,以评估免疫反应和潜在的细胞因子经胎盘转移。
    对4个数据库进行了全面搜索,以确定相关研究。纳入标准包括测量孕妇和/或其新生儿中个体细胞因子的研究。研究进行了质量评估,并提取数据进行分析。采用随机效应模型进行Meta分析。
    17项研究符合纳入标准,包括748名孕妇和287名婴儿的数据。其中超过三项研究评估了母体血清中20种细胞因子的数据,10种细胞因子的数据可从脐带血样本中获得。与SARS-CoV-2阴性孕妇(n=409)相比,SARS-CoV-2阳性孕妇(n=339)中只有CXCL10的血清水平显着上调。在COVID-19感染急性期收集的母体样本(n=183)的子集分析显示CXCL10和IFN-γ升高。从妊娠期间有(n=97)和没有(n=190)COVID-19的母亲出生的婴儿收集的脐带血样本之间的细胞因子水平没有显着差异。在孕产妇感染急性期收集的脐带血样本的子集分析受到数据不足的限制。这些研究之间的异质性是巨大的。
    研究结果表明,母亲对SARS-CoV-2感染的反应在怀孕期间没有显著失调,在疾病的急性期,CXCL10和IFN-γ除外。未观察到脐带血样本中细胞因子水平升高的证据,尽管这可能受到从最初的母体感染到脐带血采集之间的时间段的影响。这些结果为父母和医疗保健提供者提供了一些保证,但由于研究的差异和局限性,应谨慎解释。
    UNASSIGNED: The COVID-19 pandemic has affected a significant number of pregnant women worldwide, but studies on immune responses have presented conflicting results. This study aims to systematically review cytokine profiles in pregnant women with SARS-CoV-2 infection and their infants to evaluate immune responses and potential transplacental transfer of cytokines.
    UNASSIGNED: A comprehensive search of 4 databases was conducted to identify relevant studies. Inclusion criteria included studies measuring individual cytokines in pregnant women and/or their neonates. Studies were evaluated for quality, and data were extracted for analysis. Meta-analyses were performed using the random-effects model.
    UNASSIGNED: Seventeen studies met the inclusion criteria, including data from 748 pregnant women and 287 infants. More than three of these studies evaluated data of 20 cytokines in maternal serum, and data of 10 cytokines was available from cord blood samples. Only the serum level of CXCL10 was significantly up-regulated in SARS-CoV-2 positive pregnant women (n = 339) compared to SARS-CoV-2 negative pregnant women (n = 409). Subset analysis of maternal samples (n = 183) collected during the acute phase of COVID-19 infection showed elevated CXCL10 and IFN-γ. No significant differences in cytokine levels were found between cord blood samples collected from infants born to mothers with (n = 97) and without (n = 190) COVID-19 during gestation. Subset analysis of cord blood samples collected during the acute phase of maternal infection was limited by insufficient data. The heterogeneity among the studies was substantial.
    UNASSIGNED: The findings suggest that maternal cytokines responses to SARS-CoV-2 infection during pregnancy are not significantly dysregulated, except for CXCL10 and IFN-γ during the acute phase of illness. No evidence of increased cytokine levels in cord blood samples was observed, although this could be impacted by the time period between initial maternal infection and cord blood collection. These results provide some reassurance to parents and healthcare providers but should be interpreted cautiously due to study variations and limitations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号